Genetics as a tool to improve cancer outcomes: ethics and policy

被引：13

作者：

Burke, W

Press, N

机构：

[1] Univ Washington, Dept Med Hist & Eth, Seattle, WA 98195 USA

[2] Oregon Hlth Sci Univ, Sch Nursing, Portland, OR 97239 USA

来源：

NATURE REVIEWS CANCER | 2006年 / 6卷 / 06期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/nrc1890

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Genetic research is rapidly increasing the opportunities for the detection of inherited cancer risk. Clinicians and policy makers must ensure the adequate evaluation of the benefits and harms of this new area of practice, address the challenges of family-based detection of individuals at risk and develop practice guidelines and educational strategies that are responsive to rapidly changing knowledge. When the benefits of testing are well established, efforts must also be made to ensure access to genetic services for all who can benefit.

引用

页码：476 / 482

页数：8

共 51 条

[1]

Ad Hoc committee on Genetic Counseling: report to the American Society of Human Genetics, 1975, AM J HUM GENET, V27, P240

[2] GENETIC PROPHECY AND GENETIC PRIVACY - CAN WE PREVENT THE DREAM FROM BECOMING A NIGHTMARE [J].

ANNAS, GJ .

AMERICAN JOURNAL OF PUBLIC HEALTH, 1995, 85 (09) :1196-1197

[3] Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].

Antoniou, A ;

Pharoah, PDP ;

Narod, S ;

Risch, HA ;

Eyfjord, JE ;

Hopper, JL ;

Loman, N ;

Olsson, H ;

Johannsson, O ;

Borg, Å ;

Pasini, B ;

Radice, P ;

Manoukian, S ;

Eccles, DM ;

Tang, N ;

Olah, E ;

Anton-Culver, H ;

Warner, E ;

Lubinski, J ;

Gronwald, J ;

Gorski, B ;

Tulinius, H ;

Thorlacius, S ;

Eerola, H ;

Nevanlinna, H ;

Syrjäkoski, K ;

Kallioniemi, OP ;

Thompson, D ;

Evans, C ;

Peto, J ;

Lalloo, F ;

Evans, DG ;

Easton, DF .

AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130

[4]

Beauchamp TL, 1989, The Principles of biomedical ethics, V3rd

[5] Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility:: Recommendation statement [J].

Berg, AO ;

Allan, JD ;

Calonge, N ;

Frame, PS ;

Gordis, L ;

Gregory, KD ;

Harris, R ;

Johnson, MS ;

Klein, JD ;

Loveland-Cherry, C ;

Moyer, VA ;

Ockene, JK ;

Petitti, DB ;

Siu, AL ;

Teutsch, SM ;

Yawn, BP .

ANNALS OF INTERNAL MEDICINE, 2005, 143 (05) :355-361

[6]

BILLINGS PR, 1992, AM J HUM GENET, V50, P476

[7] TRANSPARENCY - INFORMED CONSENT IN PRIMARY CARE [J].

BRODY, H .

HASTINGS CENTER REPORT, 1989, 19 (05) :5-9

[8] American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility [J].

Bruinooge, SS .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2397-2406

[9] Science and society - Ensuring the appropriate use of genetic tests [J].

Burke, W ;

Zimmern, RL .

NATURE REVIEWS GENETICS, 2004, 5 (12) :955-959

[10] Recommendations for follow-up care of individuals with an inherited predisposition to cancer .1. Hereditary nonpolyposis colon cancer [J].

Burke, W ;

Petersen, G ;

Lynch, P ;

Botkin, J ;

Daly, M ;

Garber, J ;

Kahn, MJE ;

McTiernan, A ;

Offit, K ;

Thomson, E ;

Varricchio, C .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (11) :915-919

← 1 2 3 4 5 6 →